Safety profile of baricitinib for the treatment of rheumatoid arthritis over a median of 3 years of treatment: an updated integrated safety analysis

Mark C. Genovese, Josef S. Smolen, Tsutomu Takeuchi, Gerd Burmester, Dennis Brinker, Terence P. Rooney, Jinglin Zhong, Mo Daojun, Chadi Saifan, Anabela Cardoso, Maher Issa, Wen Shuo Wu, Kevin L. Winthrop

Research output: Contribution to journalArticlepeer-review

47 Scopus citations

Fingerprint

Dive into the research topics of 'Safety profile of baricitinib for the treatment of rheumatoid arthritis over a median of 3 years of treatment: an updated integrated safety analysis'. Together they form a unique fingerprint.

Medicine & Life Sciences